Summary Photaffinity labelling (PAL) with [32P]8-azido-cAMP and polyacrylamide gel electrophoresis (PAGE) has been used to identify three specific cAMP-binding proteins (cAMP-BPs) within cytosols derived from the centre and periphery of 32 human colorectal cancers and from related adjacent (less than 5 cm from the tumour) and distant (more than 5 cm from the tumour) microscopically benign mucosa. By immunoprecipitation with specific anti-RI and anti-RII antibodies these proteins have subsequently been characterised as a single form of RI (48 kDa 
Summary Photaffinity labelling (PAL) with [32P] 8-azido-cAMP and polyacrylamide gel electrophoresis (PAGE) has been used to identify three specific cAMP-binding proteins (cAMP-BPs) within cytosols derived from the centre and periphery of 32 human colorectal cancers and from related adjacent (less than 5 cm from the tumour) and distant (more than 5 cm from the tumour) microscopically benign mucosa. By immunoprecipitation with specific anti-RI and anti-RII antibodies these proteins have subsequently been characterised as a single form of RI (48 kDa) and two forms of RII (50 and 52 kDa). The relative expression of isoforms in each specimen has been quantified by laser densitometry. There was significantly more RI expressed in both tumour centre and periphery than in either adjacent or distant mucosa (P<0.008 by Wilcoxon signed-rank test). There was no significant difference in relative RI expression between tumour centre and periphery, or between adjacent and distant mucosa. There was no association between relative RI expression and Dukes' stage. Poorly differentiated tumours expressed significantly more RI than those that were either moderately or well differentiated (P = 0.016 by Mann-Whitney U-test) . This study is the first to have characterised cAMP-BPs within human colorectal tissues and has demonstrated that colorectal cancers, and in particular those of poor histological grade, relatively overexpress RI when compared with related benign mucosa.
Cyclic adenosine 3', 5'-monophosphate (cAMP) mediates the effects of a wide range of hormones and interacts with other secondary messenger systems (Suppatone et al., 1988; Ball et al., 1990) to exert control over basic cell processes such as proliferation and differentiation (Cho-Chung, 1989) . Cyclic AMP binds to and activates its dependent protein kinase, also known as protein kinase A (PK-A) (Walsh, 1968) . In its inactive form PK-A exists as a tetramer of two regulatory (R) subunits that bind cAMP (also known as cAMP-binding proteins or cAMP-BPs) and two catlytic (C) subunits that possess serine/threonine kinase activity. On binding of four cAMPs the holoenzyme dissociates into its component parts, allowing free C subunits to phosphorylate target proteins.
Regulatory subunits play an important role in modulating kinase activity by localising it to different cellular compartments (DeCamilli et al., 1986; Cho-Chung et al., 1988; Linask & Green, 1989) and by acting as pseudosubstrate in the absence of cAMP. R subunits are extremely heterogeneous, with at least four separate R subunit genes now being recognised (Lee et al., 1983; Jahnsen et al., 1986a,b; Scott et al., 1987; Sandberg et al., 1988) , and with yet more diversity at the mRNA level (Oyen et al., 1989; Sandberg et al., 1990) . In addition to their regulatory role, R subunits may act independently to control gene expression, perhaps by entering the nucleus (Cho-Chung et al., 1988) and binding to DNA (Sikorska et al., 1988; Wu & Wang, 1989) . In general, RI isoforms predominate in proliferating, developing (Lorimer et al., 1987; Gentleman et al., 1989a) transformed (Gharret et al., 1986) and malignant cells (Gentleman et al., 1989b) , while RII isoforms may programme for differentiation (Haddox et al., 1979) .
Previous work has shown that human colorectal cancers bind significantly more cAMP than related benign mucosa, suggesting that the development of colorectal cancer is associated with an abnormality in cAMP-BP expression (Bradbury et al., 1991) . Furthermore, cAMP analogues inhibit the growth and promote the differentiation of a human colorectal cancer cell line together with a reduction in RI and an increase in RII expression (Tagliaferri et al., 1988) . To (Bradford, 1976 Immunoprecipitation of cAMP-binding proteins with specific monoclonal antibodies Photoactivated incorporation of V32P]8-azido-cAMP was carried out as above. Radioinert 10 nM cAMP (5 gsl) was added to the reaction mixture and immunoprecipitation performed using specific anti-RI and anti-RII antibodies and protein A-Sepharose. Following two washes with phosphate-buffered saline, pellets of antigen-antibody complex were solubilised and subjected to electrophoretic separation.
Polyacrylamide gel electrophoresis Separating gel contained 12% acrylamide/BIS (Bio-Rad), 4.5% Tris (pH 8.8), 0.05% SDS, 0.08% TEMED (Bio-Rad) and 0.06% ammonium persulphate (Fisons). Stacking gel contained 4% acrylamide/BIS, 1.5% Tris (pH 6.8), 0.1% SDS, 0.1% TEMED and 0.05% ammonium persulphate. Samples were run at 35 mA per gel.
Transblotting of cAMP-binding proteins Transblotting was performed by a method adapted from that of Towbin (1979) . Gels were soaked in transfer buffer containing 25 mM Tris, 0.15 M sodium chloride, 2 ,UM EDTA and 0. 1% Nonidet NP-40 (Bio-Rad) for 15 min. Electrophoretic transfer was conducted overnight at 4°C and at 60 V with no current limit.
azido-cAMP, co-migrate with R65 in tissue cytosols and to show only limited displacement with cAMP (data not shown). It was therefore concluded that this protein represented albumin within the cytosols and was not a novel cAMP-BP.
Identification of R52, 50 and 48 as forms of RI! and RI Immunoprecipitation of tumour and mucosa cytosols with specific antibodies of RI and RII followed by PAL and PAGE confirmed that R52 and R50 were both forms of RII and that R48 represented a single form of RI (Figure 2 ). These proteins could therefore be termed RII-52, RII-50 and RI-48 respectively. Immunoprecipitation of commercially obtained, partially purified animal RI (48 kDa) and RII (56 kDa) showed these preparations to be extremely heterogeneous. Figure 3 show the strong positive correlation between values in tumour centre and periphery and the equal distribution of points along the line x = y. Similar observations were apparent for adjacent and distant mucosa (Figure 4) . However, the correlation in RI expression between adjacent and tumour periphery is much poorer and there is a clear tendency for values to be higher in the tumour periphery ( Figure 5 ). (Table II) . RI expression in adjacent and distant mucosa was not affected by the stage or grade of the tumour to which they were related (data not shown).
Discussion
This is the first study to have characterised the pattern of PK-A R-subunit expression in human colorectal tissues, although our previous work has shown that the periphery of human colorectal cancers may possess increased total cAMPbinding levels (Bradbury et al., 1991) . main types with molecular weights of 48, 50 and 52 kDa. Other species of low molecular weight were also detected but constituted less than 15% of the total cAMP-BPs present. These smaller molecules have been detected by other workers and are generally considered to be degradation products (Rannels & Corbin, 1979) . Immunoprecipitation with specific anti-RI and anti-RII antibodies showed that the 48 kDa moiety was a form of RI, while both the 50 kDa and 52 kDa moieties were forms of RII. The relationship of RII-50 to RII-52 is unknown. It is possible that they represent the dephosphorylated and autophosphorylated forms of RII respectively (Rangel-Aldao et al., 1979) . Alternatively, they may be separate gene products. The second novel finding of the study is that there is significantly more RI-48 in both the centre and periphery of human colorectal cancers when compared with paired adjacent and distant benign mucosa. In contrast, RII-50 and particularly RII-52 were reduced in cancers. Malignant colorectal tissues therefore relatively overexpress RI-48 when compared with benign mucosa. To our knowledge, the only other published work on R-subunit expression in colorectal tissues was performed by Tagliaferri et al. (1988) on a human cell line LS-174T. This was found to express predominantly a 47 kDa RI protein but also to express lesser amounts of 52 and 54 kDa RII proteins. Interestingly, treatment with the cAMP analogue 8-Cl-cAMP resulted in an inhibition of growth and the promotion of morphological differentiation. These effects were associated with a reduction in RI but an increase in RII expression within the cell line. The relationship between these RII isoforms and the RII isoforms detected in the present study is unknown. However, the same antibodies were used for detection and so it is possible that they are, in fact, the same proteins and that differences in technique account for the small differences observed in molecular weight. Although cell lines have been relatively well investigated with regard to cAMP-binding protein patterns, to our knowledge this is the first study to have examined the pattern of cAMP-binding proteins within a resected human cancer. Other workers have looked at the expression of kinase activity within other types of human tumours, and the results from these studies would appear to support the observations made in this paper. Fossberg et al. (1978) found the PKAI/II ratio within a human renal cell carcinoma to be approximately twice that found in normal renal cortex. Yasui et al. (1985) found that while normal human gastric mucosa had a PK-AI/II ratio of 0.2, in xenotransplantable human gastric carcinomas it was approximately 0.6, leading them to conclude that type I PK-A was a biochemical marker for malignant transformation. The present work also shows that RI is particularly highly expressed in tumour of poor histological grade. This is in contrast to the studies of Fossberg et al. (1978) and Yasui et al. (1985) , who were unable to demonstrate any association between type I PK-A kinase activity and histological grade. Taken together, these results and the present study provide evidence for excess PK-AI and RI expression in three separate human malignancies (renal, gastric, colorectal) . It is possible, therefore, that such overexpression is a general phenomenon associated with carcinogenesis.
The present study also demonstrates a strong correlation between RI expression in tumour and mucosa from the same patient, suggesting that the relative overexpression of RI is superimposed upon a background level of RI expression which is highly variable between different individuals. It is interesting to speculate whether these differences reflect differences in cell proliferation as a hyperproliferative mucosa is generally proposed as the first detectable step in the process of colorectal carcinogenesis and is believed to affect the entire colon (Terpstra et al., 1987) .
In conclusion, this study is the first to have characterised cAMP-binding protein expression in human colorectal tissues and has demonstrated that resected human colorectal cancers, like human colon cancer cell lines, relatively overexpress RI cAMP-binding protein. Furthermore, a high level of RI expression is associated with poor histological grade. The observation that cAMP analogues can inhibit the growth and promote the differentiation of human colon cancer cell lines in vitro together with a reduction in RI expression suggests that such analogues may be able to exert biological control of colorectal cancers in vivo.
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